U.S. Physical Therapy, Inc. (NYSE:USPH) Plans Quarterly Dividend of $0.30
U.S. Physical Therapy, Inc. (NYSE:USPH) declared a quarterly dividend on Wednesday, July 3rd, NASDAQ reports. Shareholders of record on Thursday, August 15th will be paid a dividend of 0.30 per share on Friday, September 13th. This represents a $1.20 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Wednesday, August 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.27.
U.S. Physical Therapy has increased its dividend by an average of 15.3% per year over the last three years and has increased its dividend every year for the last 8 years. U.S. Physical Therapy has a payout ratio of 47.8% meaning its dividend is sufficiently covered by earnings. Research analysts expect U.S. Physical Therapy to earn $3.21 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 37.4%.
Shares of NYSE USPH opened at $133.38 on Tuesday. The firm has a market cap of $1.68 billion, a PE ratio of 50.33, a PEG ratio of 3.99 and a beta of 1.13. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a fifty day moving average of $126.06. U.S. Physical Therapy has a fifty-two week low of $98.69 and a fifty-two week high of $135.01.
Several equities analysts have weighed in on the company. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 price objective for the company in a report on Friday, April 26th. Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. U.S. Physical Therapy currently has an average rating of “Buy” and a consensus target price of $113.54.
In related news, CFO Lawrance W. Mcafee sold 2,500 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $131.50, for a total transaction of $328,750.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Christopher J. Reading sold 19,860 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total value of $2,370,489.60. The disclosure for this sale can be found here. 2.50% of the stock is currently owned by insiders.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Article: When is a capital gain realized?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.